Clinical Trial Update: Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating initiating Type 2 diabetes treatment with a combination of dapagliflozin and metformin XR; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• metformin XR (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2014-03-20